ProfileGDS4459 / ENSG00000105401
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 73% 58% 76% 65% 73% 41% 78% 71% 79% 76% 71% 76% 73% 68% 73% 69% 61% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 15.4173
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 24.6558
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 35.976
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 45.0365
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 55.5273
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 64.0741
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 76.0478
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 85.4371
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 96.179
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 105.8176
GSM623474group B, liver allograft wedge biopsie placebo treatment 15.3271
GSM623475group B, liver allograft wedge biopsie placebo treatment 25.976
GSM623476group B, liver allograft wedge biopsie placebo treatment 35.5673
GSM623477group B, liver allograft wedge biopsie placebo treatment 45.0868
GSM623478group B, liver allograft wedge biopsie placebo treatment 55.6773
GSM623479group B, liver allograft wedge biopsie placebo treatment 65.1469
GSM623480group B, liver allograft wedge biopsie placebo treatment 74.7661